A carregar...

Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases

Apatinib, an oral small molecular receptor tyrosine kinase inhibitor (TKI) developed first in China, exerts antiangiogenic and antineoplastic function through selectively binding and inhibiting vascular endothelial growth factor receptor 2 (VEGFR-2). In this study, we aimed to explore the efficacy a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Res
Main Authors: Xu, Jianping, Liu, Xiaoyan, Yang, Sheng, Shi, Yuankai
Formato: Artigo
Idioma:Inglês
Publicado em: Cognizant Communication Corporation 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851530/
https://ncbi.nlm.nih.gov/pubmed/31610827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504019X15707896762251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!